• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CPEB3 通过将 ADAR1 mRNA 定位到 P 体来抑制 ADAR1 介导的 RNA 编辑,从而抑制胃癌的进展。

CPEB3 suppresses gastric cancer progression by inhibiting ADAR1-mediated RNA editing via localizing ADAR1 mRNA to P bodies.

机构信息

Center for Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

Department of Clinical Microbiology Laboratory, Institute of Laboratory Medicine, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, School of Medical Technology, Guangdong Medical University, Dongguan, Guangdong, China.

出版信息

Oncogene. 2022 Oct;41(41):4591-4605. doi: 10.1038/s41388-022-02454-z. Epub 2022 Sep 6.

DOI:10.1038/s41388-022-02454-z
PMID:36068334
Abstract

Deciphering the crosstalk between RNA-binding proteins and corresponding RNAs will provide a better understanding of gastric cancer (GC) progression. The comprehensive bioinformatics study identified cytoplasmic polyadenylation element-binding protein 3 (CPEB3) might play a vital role in GC progression. Then we found CPEB3 was downregulated in GC and correlated with prognosis. In addition, CPEB3 suppressed GC cell proliferation, invasion and migration in vitro, as well as tumor growth and metastasis in vivo. Mechanistic study demonstrated CPEB3 interacted with 3'-UTR of ADAR1 mRNA through binding to CPEC nucleotide element, and then inhibited its translation by localizing it to processing bodies (P bodies), eventually leading to the suppression of ADAR1-mediated RNA editing. Microscale thermophoresis assay further revealed that the direct interaction between CPEB3 and GW182, the P-body's major component, was through the 440-698AA region of CPEB3 binding to the 403-860AA region of GW182. Finally, AAV9-CPEB3 was developed and administrated in mouse models to assess its potential value in gene therapy. We found AAV9-CPEB3 inhibited GC growth and metastasis. Besides, AAV9-CPEB3 induced hydropic degeneration in mouse liver, but did not cause kidney damage. These findings concluded that CPEB3 suppresses GC progression by inhibiting ADAR1-mediated RNA editing via localizing ADAR1 mRNA to P bodies.

摘要

解析 RNA 结合蛋白与相应 RNA 之间的串扰将有助于更好地理解胃癌(GC)的进展。全面的生物信息学研究表明细胞质多聚腺苷酸化元件结合蛋白 3(CPEB3)可能在 GC 进展中发挥重要作用。然后我们发现 CPEB3 在 GC 中下调,并与预后相关。此外,CPEB3 在体外抑制 GC 细胞增殖、侵袭和迁移,以及体内肿瘤生长和转移。机制研究表明 CPEB3 通过结合 CPEC 核苷酸元件与 ADAR1 mRNA 的 3'-UTR 相互作用,然后通过将其定位到处理体(P 体)中来抑制其翻译,最终导致 ADAR1 介导的 RNA 编辑受到抑制。微量热泳动分析进一步表明,CPEB3 与 P 体主要成分 GW182 的直接相互作用是通过 CPEB3 的 440-698AA 区域与 GW182 的 403-860AA 区域结合实现的。最后,开发了 AAV9-CPEB3 并在小鼠模型中进行了给药,以评估其在基因治疗中的潜在价值。我们发现 AAV9-CPEB3 抑制 GC 的生长和转移。此外,AAV9-CPEB3 诱导小鼠肝脏水肿变性,但不会引起肾脏损伤。这些发现表明,CPEB3 通过将 ADAR1 mRNA 定位到 P 体来抑制 ADAR1 介导的 RNA 编辑,从而抑制 GC 的进展。

相似文献

1
CPEB3 suppresses gastric cancer progression by inhibiting ADAR1-mediated RNA editing via localizing ADAR1 mRNA to P bodies.CPEB3 通过将 ADAR1 mRNA 定位到 P 体来抑制 ADAR1 介导的 RNA 编辑,从而抑制胃癌的进展。
Oncogene. 2022 Oct;41(41):4591-4605. doi: 10.1038/s41388-022-02454-z. Epub 2022 Sep 6.
2
Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.组合 RNA 测序分析揭示 ADAR1 在胃癌中双重调控基因的模式。
Dig Dis Sci. 2018 Jul;63(7):1835-1850. doi: 10.1007/s10620-018-5081-9. Epub 2018 Apr 25.
3
Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.环状 RNA hsa_circ_0004872 通过 miR-224/Smad4/ADAR1 连续调控回路抑制胃癌进展。
Mol Cancer. 2020 Nov 10;19(1):157. doi: 10.1186/s12943-020-01268-5.
4
Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.增强的 AZIN1 RNA 编辑和其调节酶 ADAR1 的过表达是胃癌的重要预后生物标志物。
J Transl Med. 2018 Dec 18;16(1):366. doi: 10.1186/s12967-018-1740-z.
5
ADAR1-mediated 3' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response.ADAR1介导的抗凋亡基因3'非翻译区编辑和表达调控精细调节细胞凋亡反应。
Cell Death Dis. 2017 May 25;8(5):e2833. doi: 10.1038/cddis.2017.12.
6
ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.ADAR1 介导的乳腺癌 3'UTR 的 RNA 编辑。
Biol Res. 2018 Oct 5;51(1):36. doi: 10.1186/s40659-018-0185-4.
7
Marburg and Ebola Virus mRNA 3' Untranslated Regions Contain Negative Regulators of Translation That Are Modulated by ADAR1 Editing.马尔堡和埃博拉病毒 mRNA 3' 非翻译区含有翻译的负调节剂,这些调节剂受 ADAR1 编辑的调节。
J Virol. 2021 Sep 9;95(19):e0065221. doi: 10.1128/JVI.00652-21.
8
RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.RNA编辑酶ADAR1和ADAR2协同调节Ctn RNA的编辑和表达。
FEBS Lett. 2017 Sep;591(18):2890-2904. doi: 10.1002/1873-3468.12795. Epub 2017 Aug 30.
9
ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.ADAR介导的RNA编辑可预测胃癌的进展和预后。
Gastroenterology. 2016 Oct;151(4):637-650.e10. doi: 10.1053/j.gastro.2016.06.043. Epub 2016 Jul 1.
10
ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.ADAR1 通过 microRNA-302a 介导的 IRF9/STAT1 调控抑制胃癌细胞中的干扰素信号通路。
Int J Mol Sci. 2020 Aug 27;21(17):6195. doi: 10.3390/ijms21176195.

引用本文的文献

1
Construction of a Prognostic Model Using RNA Processing Factor Genes and the Key Role of NSUN6 in Glioma Outcomes.利用RNA加工因子基因构建预后模型及NSUN6在胶质瘤预后中的关键作用
J Cell Mol Med. 2025 Jun;29(12):e70668. doi: 10.1111/jcmm.70668.
2
MiR-103-3p regulates chondrocyte autophagy, apoptosis, and ECM degradation through the PI3K/Akt/mTOR pathway by targeting CPEB3.微小RNA-103-3p通过靶向CPEB3,经由PI3K/Akt/mTOR信号通路调控软骨细胞的自噬、凋亡及细胞外基质降解。
J Orthop Surg Res. 2025 Mar 29;20(1):324. doi: 10.1186/s13018-025-05719-x.
3
Praja2 controls P-body assembly and translation in glioblastoma by non-proteolytic ubiquitylation of DDX6.

本文引用的文献

1
Robust single-cell discovery of RNA targets of RNA-binding proteins and ribosomes.稳健的单细胞发现 RNA 结合蛋白和核糖体的 RNA 靶标。
Nat Methods. 2021 May;18(5):507-519. doi: 10.1038/s41592-021-01128-0. Epub 2021 May 7.
2
ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells.ADAR1 RNA 编辑酶调节癌细胞中端粒处 R 环的形成和基因组稳定性。
Nat Commun. 2021 Mar 12;12(1):1654. doi: 10.1038/s41467-021-21921-x.
3
Current treatment and recent progress in gastric cancer.胃癌的当前治疗方法和最新进展。
Praja2通过对DDX6进行非蛋白水解性泛素化来控制胶质母细胞瘤中的P小体组装和翻译。
EMBO Rep. 2025 May;26(9):2347-2377. doi: 10.1038/s44319-025-00425-5. Epub 2025 Mar 27.
4
The role of miR-92b-3p in notch signaling and monitoring of oral squamous cell carcinoma.miR-92b-3p在口腔鳞状细胞癌的Notch信号传导及监测中的作用
Oncogene. 2025 May;44(18):1300-1311. doi: 10.1038/s41388-025-03306-2. Epub 2025 Feb 18.
5
Cytoplasmic regulation of the poly(A) tail length as a potential therapeutic target.聚腺苷酸尾长度的细胞质调控作为一种潜在的治疗靶点。
RNA. 2025 Feb 19;31(3):402-415. doi: 10.1261/rna.080333.124.
6
ADAR1 Promotes Myogenic Proliferation and Differentiation of Goat Skeletal Muscle Satellite Cells.ADAR1 促进山羊骨骼肌卫星细胞的肌生成增殖和分化。
Cells. 2024 Sep 25;13(19):1607. doi: 10.3390/cells13191607.
7
circKDM1A suppresses bladder cancer progression by sponging miR-889-3p/CPEB3 and stabilizing p53 mRNA.环状KDM1A通过吸附miR-889-3p/CPEB3并稳定p53 mRNA来抑制膀胱癌进展。
iScience. 2024 Mar 29;27(4):109624. doi: 10.1016/j.isci.2024.109624. eCollection 2024 Apr 19.
8
Prognostic biomarker CPEB3 and its associations with immune infiltration in clear cell renal cell carcinoma.预后生物标志物CPEB3及其与透明细胞肾细胞癌免疫浸润的关联。
Biomed Rep. 2024 Feb 19;20(4):63. doi: 10.3892/br.2024.1751. eCollection 2024 Apr.
9
The role of ADAR1 through and beyond its editing activity in cancer.ADAR1 在癌症中的作用及其编辑活性以外的作用。
Cell Commun Signal. 2024 Jan 17;22(1):42. doi: 10.1186/s12964-023-01465-x.
10
Prognostic analysis and risk assessment based on RNA editing in hepatocellular carcinoma.基于 RNA 编辑的肝细胞癌预后分析与风险评估。
J Appl Genet. 2024 Sep;65(3):519-530. doi: 10.1007/s13353-023-00819-y. Epub 2024 Jan 13.
CA Cancer J Clin. 2021 May;71(3):264-279. doi: 10.3322/caac.21657. Epub 2021 Feb 16.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
RNA-binding proteins in human genetic disease.人类遗传疾病中的 RNA 结合蛋白。
Nat Rev Genet. 2021 Mar;22(3):185-198. doi: 10.1038/s41576-020-00302-y. Epub 2020 Nov 24.
6
TRIM11 stimulates the proliferation of gastric cancer through targeting CPEB3/EGFR axis.TRIM11 通过靶向 CPEB3/EGFR 轴促进胃癌的增殖。
J BUON. 2020 Jul-Aug;25(4):2097-2104.
7
CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.CPEB3 通过阻断结直肠癌细胞与肿瘤相关巨噬细胞之间的细胞因子信号转导及转录激活因子 3(IL-6R/STAT3)信号通路来抑制上皮-间质转化。
J Exp Clin Cancer Res. 2020 Jul 11;39(1):132. doi: 10.1186/s13046-020-01637-4.
8
ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.ADAR1 介导的 RNA 编辑是甲状腺癌中的一种新的致癌过程,调节 miR-200 的活性。
Oncogene. 2020 Apr;39(18):3738-3753. doi: 10.1038/s41388-020-1248-x. Epub 2020 Mar 10.
9
Engineering adeno-associated virus vectors for gene therapy.工程腺相关病毒载体用于基因治疗。
Nat Rev Genet. 2020 Apr;21(4):255-272. doi: 10.1038/s41576-019-0205-4. Epub 2020 Feb 10.
10
Endoplasmic reticulum contact sites regulate the dynamics of membraneless organelles.内质网接触位点调节无膜细胞器的动态。
Science. 2020 Jan 31;367(6477). doi: 10.1126/science.aay7108.